Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer

被引：0

作者：

Kim, Y. T. ^{[1
]}

Kim, H. S. ^{[2
]}

Shin, S. J. ^{[2
]}

Beom, S-H. ^{[2
]}

Kim, N. K. ^{[3
]}

Lee, K. Y. ^{[3
]}

Min, B. S. ^{[3
]}

Hur, H. ^{[3
]}

Cho, M. S. ^{[3
]}

Han, Y. D. ^{[3
]}

Yang, S. Y. ^{[3
]}

Koom, W. S. ^{[4
]}

Chang, J. S. ^{[4
]}

Kim, T. I. ^{[5
]}

Cheon, J. H. ^{[5
]}

Park, S. J. ^{[5
]}

Park, J. J. ^{[5
]}

Seo, N. E. ^{[6
]}

Lim, J. S. ^{[6
]}

Ahn, J. B. ^{[2
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea

[2] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea

[3] Yonsei Univ, Dept Surg, Yonsei Canc Ctr, Seoul, South Korea

[4] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea

[5] Yonsei Univ, Yonsei Canc Ctr, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea

[6] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.528

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

417P

引用

页码：S418 / S419

页数：2

共 50 条

[41] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer [J].

Moretto, Roberto ;

Falcone, Alfredo ;

Cremolini, Chiara .

INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) :2652-2654

[42] High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal [J].

Babcock, Blake D. ;

Aljehani, Mayada A. ;

Jabo, Brice ;

Choi, Audrey H. ;

Morgan, John W. ;

Selleck, Matthew J. ;

Luca, Fabrizio ;

Raskin, Elizabeth ;

Reeves, Mark E. ;

Garberoglio, Carlos A. ;

Lum, Sharon S. ;

Senthil, Maheswari .

ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) :1980-1985

[43] High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal [J].

Blake D. Babcock ;

Mayada A. Aljehani ;

Brice Jabo ;

Audrey H. Choi ;

John W. Morgan ;

Matthew J. Selleck ;

Fabrizio Luca ;

Elizabeth Raskin ;

Mark E. Reeves ;

Carlos A. Garberoglio ;

Sharon S. Lum ;

Maheswari Senthil .

Annals of Surgical Oncology, 2018, 25 :1980-1985

[44] Recent approaches to identifying biomarkers for high-risk stage II colon cancer [J].

Akiyoshi, Takashi ;

Kobunai, Takashi ;

Watanabe, Toshiaki .

SURGERY TODAY, 2012, 42 (11) :1037-1045

[45] Recent approaches to identifying biomarkers for high-risk stage II colon cancer [J].

Takashi Akiyoshi ;

Takashi Kobunai ;

Toshiaki Watanabe .

Surgery Today, 2012, 42 :1037-1045

[46] High-risk Stage II Colon Cancer: Not All Risks Are Created Equal [J].

Babcock, B. D. ;

Aljehani, M. ;

Jabo, B. ;

Choi, A. ;

Morgan, J. W. ;

Selleck, M. J. ;

Luca, F. ;

Raskin, E. ;

Reeves, E. ;

Garberoglio, C. A. ;

Lum, S. S. ;

Senthil, M. .

ANNALS OF SURGICAL ONCOLOGY, 2018, 25 :S34-S34

[47] Identification of patients with high-risk stage II colon cancer for adjuvant therapy [J].

Quah, Hak-Mien ;

Chou, Joanne F. ;

Gonen, Mithat ;

Shia, Jinru ;

Schrag, Deborah ;

Landmann, Ron G. ;

Guillem, Jose G. ;

Paty, Philip B. ;

Temple, Larissa K. ;

Wong, W. Douglas ;

Weiser, Martin R. .

DISEASES OF THE COLON & RECTUM, 2008, 51 (05) :503-507

[48] Meeting the 12 Lymph Node (LN) Benchmark in Colon Cancer [J].

Rajput, A. ;

Romanus, D. ;

Weiser, M. R. ;

Ter Veer, A. ;

Niland, J. ;

Wilson, J. ;

Skibber, J. M. ;

Wong, Y. -N. ;

Benson, A. ;

Earle, C. C. ;

Schrag, D. .

JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (01) :3-9

[49] How to improve outcome in high-risk stage III colon cancer with dMMR gene [J].

Abdelsalam, Y. ;

Elbaiomy, M. .

ANNALS OF ONCOLOGY, 2023, 34 :S28-S28

[50] Clinical Impact of Elastic Laminal Invasion in Colon Cancer: Elastic Laminal Invasion-Positive Stage II Colon Cancer Is a High-Risk Equivalent to Stage III [J].

Yokota, Mitsuru ;

Kojima, Motohiro ;

Nomura, Shogo ;

Nishizawa, Yusuke ;

Kobayashi, Akihiro ;

Ito, Masaaki ;

Ochiai, Atsushi ;

Saito, Norio .

DISEASES OF THE COLON & RECTUM, 2014, 57 (07) :830-838

← 1 2 3 4 5 →